FMI opines the nasal mucosa therapeutics market was valued at USD 5.0 billion in 2025. The industry is expected to reach USD 5.9 billion in 2026 and USD 31.7 billion by 2036. Dry eye disease is poised to dominate by Target Indication with 60.0% share in 2026, and small molecule is projected to lead by Type of Molecule through the forecast period.